Ampleia is a venture-building organization dedicated to support rare diseases therapeutics projects. We work with exceptional scientists and entrepreneurs developing therapeutic options for under-served indications. We act as an operating co-founder from day 1, bringing funding, translational development capabilities and corporate support. We are from each decision to prepare the founders and the company to Series A or strategic deal. We adopt a technology-agnostic approach and work on projects from anywhere in the world.
Company Details
- Employees
- 5
- Founded
- 2023
- Address
- 1 Bis Rue De L'internationale, Evry-Courcouronnes,91000,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ampleia.eu
- HQ
- EVRY-COURCOURONNES
Ampleia Questions
Ampleia's website is http://www.ampleia.eu
Ampleia's LinkedIn profile is https://fr.linkedin.com/company/ampleia
Ampleia has
5 employees.
View email and phone details for 5
employees at Ampleia.
Ampleia's industry is
Biotechnology Research
Ampleia's top competitors are
Finpact,
Abcely,
Atopia Therapeutics,
Accure Therapeutics,
Immungenetics Ag,
Orphanse Healthcare,
Carbozym,
Axoltis Pharma,
Adbio Partners,
Algenscribe Sas.
Ampleia's categories are Biotechnology Research
Ampleia's founding year is 2023
